featured
Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-Term Responders
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ophthalmology Retina
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-Term Responders: A Prospective Spectral-Domain OCT Study
Ophthalmol Retina 2020 Dec 01;4(12)1138-1145, G Bontzos, S Bagheri, L Ioanidi, I Kim, I Datseris, E Gragoudas, S Kabanarou, J Miller, M Tsilimbaris, DG VavvasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.